Skip to main content
Menu
US
bispecific-antibody1920x640
Application Note

High throughput platforms to characterize a bispecific antibody subjected to force degradation

Forced degradation studies are critical in therapeutic antibody research, helping to evaluate stability across the product lifecycle. Common degradation pathways include aggregation, deamidation, oxidation, and fragmentation, with thermal stress being a frequently studied factor.

This application note explores the stability of a bispecific antibody targeting mouse CD200 and CD47 under thermal stress, using a high-throughput, no-wash HTRF™ assay to assess its binding activity.

Read this application note to learn more.

For research use only. Not for use in diagnostic procedures.

To view the full content please answer a few questions

By submitting my personal data, I acknowledge that Revvity Inc. and its affiliates (“Company”) will process my personal data provided above consistent with the Company’s Privacy Policy available here.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Download Resource

High throughput platforms to characterize a bispecific antibody subjected to force degradation